Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS
NCT04145284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6
Last updated 2021-03-24
Summary
The primary objective is to assess the performance of a new magnetic resonance imaging (MRI) metrics software prototype when used in radiological practice in multiple sclerosis (MS).
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Biogen
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-30
- Primary Completion
- 2020-04-30
- Completion
- 2020-04-30
Countries
- United States
- Germany
Study Locations
More Related Trials
-
Investigation of GM Pathology Using Ultra High Field (7T) MRI Scanner
NCT01805986 ·Status: UNKNOWN
-
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
NCT00321568 ·Status: COMPLETED
-
Study of New Magnetic Resonance Methods
NCT00001844 ·Status: TERMINATED
-
A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage
NCT05106465 ·Status: COMPLETED
-
Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis
NCT02058732 ·Status: TERMINATED ·Phase: NA
-
Neuromelanin MRI: A Progression Marker in Early PD
NCT05631158 ·Status: UNKNOWN
-
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
NCT01211873 ·Status: COMPLETED ·Phase: PHASE3
-
Natural History of Multiple Sclerosis and Its Mimickers
NCT02504840 ·Status: COMPLETED
-
Low Field Magnetic Resonance Imaging Assessment With Outpatients
NCT05582785 ·Status: RECRUITING ·Phase: NA
-
Comparison of the Performance of an Optimized 3D EPI SWI Sequence and a Non-EPI QSM SWI Sequence in Detecting the Central Vein Sign in Patients With Multiple Sclerosis
NCT04705870 ·Status: COMPLETED
-
Macromolecular Imaging of White and Gray Matter Pathology in Multiple Sclerosis
NCT04415372 ·Status: ENROLLING_BY_INVITATION
-
Quantitative Non-Invasive Brain Imaging Using QUTE-CE MRI
NCT03266848 ·Status: COMPLETED
-
Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI
NCT06955832 ·Status: RECRUITING
-
Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
NCT02836327 ·Status: UNKNOWN
-
Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects
NCT05604534 ·Status: RECRUITING
-
Brain Diseases on 7.0T Magnetic Resonance Imaging
NCT05287750 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
NCT00393588 ·Status: COMPLETED
-
GTA-MEG as a Biomarker for Cognition in MS
NCT02851342 ·Status: COMPLETED
-
Accurate Diagnosis of Multiple Sclerosis Using PET/MR
NCT04521439 ·Status: COMPLETED ·Phase: NA
-
MRI Exploration of Meningeal Inflammatory Disease
NCT04707170 ·Status: COMPLETED
-
Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging
NCT00709852 ·Status: COMPLETED ·Phase: PHASE3
-
Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy
NCT01045044 ·Status: WITHDRAWN
-
Magnetic Resonance Imaging in Metabolic Diseases
NCT06709846 ·Status: RECRUITING
-
Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)
NCT01945853 ·Status: WITHDRAWN ·Phase: NA
-
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
NCT03270059 ·Status: RECRUITING ·Phase: PHASE2